Logo image of GIBO

GIBO HOLDINGS LTD-CL A (GIBO) Stock Fundamental Analysis

USA - NASDAQ:GIBO - KYG386171097 - Common Stock

3 USD
+0.05 (+1.69%)
Last: 9/12/2025, 8:00:01 PM
3.04 USD
+0.04 (+1.33%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

1

GIBO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 69 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of GIBO have multiple concerns. GIBO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year GIBO was profitable.
GIBO had a negative operating cash flow in the past year.
GIBO Yearly Net Income VS EBIT VS OCF VS FCFGIBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

GIBO has a Return On Assets of 3.66%. This is in the better half of the industry: GIBO outperforms 65.22% of its industry peers.
GIBO's Return On Equity of 4.00% is fine compared to the rest of the industry. GIBO outperforms 65.22% of its industry peers.
Industry RankSector Rank
ROA 3.66%
ROE 4%
ROIC N/A
ROA(3y)3.73%
ROA(5y)N/A
ROE(3y)96.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GIBO Yearly ROA, ROE, ROICGIBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

GIBO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GIBO Yearly Profit, Operating, Gross MarginsGIBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

2

2. Health

2.1 Basic Checks

The number of shares outstanding for GIBO has been reduced compared to 1 year ago.
Compared to 1 year ago, GIBO has a worse debt to assets ratio.
GIBO Yearly Shares OutstandingGIBO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10K 20K 30K
GIBO Yearly Total Debt VS Total AssetsGIBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 1.98 indicates that GIBO is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.98, GIBO is in line with its industry, outperforming 55.07% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that GIBO is not too dependend on debt financing.
GIBO's Debt to Equity ratio of 0.05 is in line compared to the rest of the industry. GIBO outperforms 57.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.98
ROIC/WACCN/A
WACCN/A
GIBO Yearly LT Debt VS Equity VS FCFGIBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M

2.3 Liquidity

GIBO has a Current Ratio of 0.01. This is a bad value and indicates that GIBO is not financially healthy enough and could expect problems in meeting its short term obligations.
GIBO has a Current ratio of 0.01. This is amonst the worse of the industry: GIBO underperforms 95.65% of its industry peers.
GIBO has a Quick Ratio of 0.01. This is a bad value and indicates that GIBO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.01, GIBO is doing worse than 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
GIBO Yearly Current Assets VS Current LiabilitesGIBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

0

3. Growth

3.1 Past

The earnings per share for GIBO have decreased strongly by -17.90% in the last year.
EPS 1Y (TTM)-17.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.08 indicates a rather cheap valuation of GIBO.
Based on the Price/Earnings ratio, GIBO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
GIBO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
Industry RankSector Rank
PE 0.08
Fwd PE N/A
GIBO Price Earnings VS Forward Price EarningsGIBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GIBO Per share dataGIBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GIBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GIBO HOLDINGS LTD-CL A

NASDAQ:GIBO (9/12/2025, 8:00:01 PM)

After market: 3.04 +0.04 (+1.33%)

3

+0.05 (+1.69%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.43%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap10.89M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.08
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)37.44
EY1248%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0
BVpS8.27
TBVpS8.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.73%
ROA(5y)N/A
ROE(3y)96.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 1.98
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-154.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-228.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-228.48%
OCF growth 3YN/A
OCF growth 5YN/A